Cepheid Names Labsco US Hospital Distributor | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid today announced that Labsco has been named a US distribution partner for its GeneXpert Systems and tests.

Labsco has exclusive US distribution rights to sell the Cepheid products to acute care hospitals with less than 150 beds. The deal does not include Cepheid's higher-throughput GeneXpert Infinity System, the Sunnyvale, Calif.-based molecular diagnostics firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.